Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA

Monitoring of early-stage breast cancer is critical in promptly addressing disease relapse. Circulating cell-free DNA provides a minimally invasive and sensitive means to probing the disease. In a longitudinal analysis of 250 patients with early breast cancer, we compared the circulating cell-free D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Zhigang, Tang, Jiying, Cai, Xiaojun, Ke, Feng, Shi, Zhenzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610146/
https://www.ncbi.nlm.nih.gov/pubmed/33044511
http://dx.doi.org/10.1042/BSR20194306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610146/
https://www.ncbi.nlm.nih.gov/pubmed/33044511
http://dx.doi.org/10.1042/BSR20194306

Ejemplares similares